People · Operator

Suresh Pai

Named in public records as an officer, director or promoter · active 2009–2022 · Other Health Care, Other, Biotechnology

3
Companies
8
Filings
$19.8M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Squareone, Inc.Other Health CareSeries A$15.9M$81.5M2009
BlackSwan Vascular, Inc.OtherSeed$2.8M$18.5M2018
Xpan Inc.BiotechnologyPre-Seed$999K$2.9M2022
Operator network

Suresh Pai at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

FARHAD KHOSRAVI · 14 companies · 1 sharedFARHAD KHOSRAVIMark Wan · 10 companies · 1 sharedMark WanAmar Sawhney · 6 companies · 1 sharedAmar SawhneyRob Kuhling · 3 companies · 1 sharedRob KuhlingLouis Soto · 2 companies · 1 sharedLouis SotoJames Dreher · 1 companies · 1 sharedJames DreherJonathan Bohane · 1 companies · 1 sharedJonathan BohaneAdrian M. Rich · 7 companies · 1 sharedAdrian M. RichSanjay Shrivastava · 2 companies · 1 sharedSanjay ShrivastavaCelso Bagaoisan · 1 companies · 1 sharedCelso BagaoisanMike Bates · 1 companies · 1 sharedMike BatesStefano Picone · 2 companies · 1 sharedStefano PiconeZaid Atto · 1 companies · 1 sharedZaid AttoSquareone, Inc. · $15.9M raisedSquareone, Inc.BlackSwan Vascular, Inc. · $2.8M raisedBlackSwan Vascular, I…Xpan Inc. · $1.0M raisedXpan Inc.Suresh PaiSP
Suresh Pai Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Suresh Pai on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
FARHAD KHOSRAVI114
Mark Wan110
Adrian M. Rich17
Amar Sawhney16
Rob Kuhling13
Stefano Picone12
Sanjay Shrivastava12
Louis Soto12
Celso Bagaoisan11
Jonathan Bohane11
Zaid Atto11
Mike Bates11
James Dreher11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.